MLL
TDOC icon

Moody Lynn & Lieberson’s Teladoc Health TDOC Stock Holding History

Moody Lynn & Lieberson’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,620
Closed -$205K – 247
2021
Q3 		$205K Hold
1,620
– – 0.02% 215
2021
Q2 		$269K Sell
1,620
-87
-5% -$14.1K 0.02% 198
2021
Q1 		$310K Sell
1,707
-58
-3% -$13.5K 0.03% 188
2020
Q4 		$353K Sell
1,765
-14,754
-89% -$3M 0.03% 168
2020
Q3 		$3.62M Buy
16,519
+14,795
+858% +$3.13M 0.36% 63
2020
Q2 		$329K Sell
1,724
-7,901
-82% -$1.38M 0.04% 149
2020
Q1 		$1.49M Buy
+9,625
New +$1.12M 0.21% 69
2018
Q4 		– Sell
-4,040
Closed -$349K – 213
2018
Q3 		$349K Buy
+4,040
New +$288K 0.04% 181

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Moody Lynn & Lieberson's TDOC Position: Q4 2021 in Review

Moody Lynn & Lieberson sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 1,620 shares — an estimated $205K sold.

Moody Lynn & Lieberson first reported a position in TDOC in Q3 2018 and held it in 8 quarters. The position peaked at $3.62M in Q3 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Moody Lynn & Lieberson reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 1,620 Teladoc Health shares in Q4 2021, an estimated $205K.
  • Moody Lynn & Lieberson first reported a position in Teladoc Health in Q3 2018 and held it in 8 quarters.
  • Moody Lynn & Lieberson's Teladoc Health position peaked at $3.62M in Q3 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2021, filed 26 Jan 2022.